PRIMO Health Partners
PRIMO Health Partners combines physician-directed weight management with a dedicated nurse and broader virtual-care services. Its public drug information contains outdated and conflicting details that need clarification with the treating clinician.
Review by Leah Garner, clinical-evidence editor · Updated October 2026
The short version
The nurse-supported care model is a useful reason to ask about PRIMO. The decisive questions are the assigned prescriber, actual pharmacy and an up-to-date written treatment plan, especially where the website’s dose information conflicts with current labeling.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
PRIMO Health Partners is a telehealth service offering weight-management programs alongside primary, urgent and specialist care. Its website agreement identifies Cooper and Company as the operator. William A. Cooper, MD, is presented as founder and chairman, and the program describes dedicated nurse support. The site discusses semaglutide and tirzepatide, with compounding pharmacies used for applicable prescriptions. A general bundle of virtual services should not be assumed to include every weight-management visit or medication.
What PRIMO Health Partners prescribes, by goal
Weight
- SemaglutideFDA-approved
Listed by the seller; no price we hold.
- TirzepatideFDA-approved
Listed by the seller; no price we hold.
The semaglutide FAQ explicitly describes a subcutaneous weekly injection. The actual prescription, formulation and titration should come from the assigned clinician. Public weight-loss forecasts and stories do not establish typical results for PRIMO’s compounded program. Ask how the plan applies to medical history and the selected preparation.
Who prescribes
A licensed clinician
The website names one physician founder, William A. Cooper, and identifies Sheila Jordan, RN, in clinical operations. The founder’s profile does not guarantee that he handles every weight-management consultation. Ask for the assigned prescriber’s name and practice contact before treatment. The program claims to assess compounding partners but does not identify the dispensing facility in the cited offer. That pharmacy should be confirmed for the actual prescription, not inferred from a general integrity statement.
The service describes a consultation before any prescription. Patients begin with a call or inquiry, have an online evaluation and receive a prescription if appropriate. A dedicated nurse provides guidance during weight-management care. The site describes doctor review for adverse effects and dose adjustment, without establishing one fixed continuing appointment interval. General twenty-four-hour telehealth access is not a promise that the weight-management prescriber is always immediately available. Clarify who handles questions and when a clinical review is required.
Are labs required?
Not mentioned
The public weight-management pages do not establish one required baseline laboratory panel, repeat-testing interval or included charge. Ask whether a test is needed before prescribing, who orders it and who reviews the results. Broader primary-care access does not prove that every diagnostic service is included within the weight-management agreement.
Ready to start with PRIMO Health Partners?
Prices and plans are set on the seller's own site.
What it claims, and what it cites
The program includes broad weight-loss forecasts and describes side effects as minimal in one section, while other sections acknowledge important risks. Its semaglutide FAQ also mixes older approval statements with current program advertising. More concerning, the posted dose discussion describes weekly increments unlike the current Wegovy injection label’s four-week escalation stages. This is a reason to obtain an individualized written prescription, not to follow the website as a dosing guide. A compounded preparation is not FDA-approved and should not inherit a brand’s trial results automatically.
Other products and treatment claims
- Urgent care, primary care and specialist second opinions
- These are separate service scopes unless explicitly included in the selected weight-management bundle.
How it bills
The site offers subscriptions and bundles combining weight management with other virtual care. A current complete standing medication rate is not established in the public program. Confirm which visits, nurse contacts, medication, tests and delivery services are included. Prescription and appointment cancellation terms need a selected-plan agreement. The general website terms do not supply a complete medication refund policy.
For and against
- For: Physician founder identified
- For: Dedicated nurse support described
- For: Clinical consultation precedes prescribing
- For: Broader virtual-care options
- Against: Public dosing text needs correction
- Against: Actual pharmacy unnamed
- Against: Fixed clinical follow-up interval unclear
- Against: Complete selected-plan price unpublished
The evidence behind what it sells
Right for
Someone seeking nurse-supported virtual care who will verify the assigned clinician and current written prescription instructions.
Look elsewhere if
Someone relying on a public dosing paragraph, expecting a named founder at every visit or assuming general telehealth access includes every service.
Other sellers for weight
AquaVita NextGen
Also prescribes Semaglutide, Tirzepatide.
Kongo
Also prescribes Semaglutide, Tirzepatide.
Rylo Health
Also prescribes Semaglutide, Tirzepatide.
PRIMO Health Partners
Frequently asked questions
- Does the founder personally prescribe every treatment?
- The website names William Cooper and describes a clinical team. It does not establish that he conducts every consultation or writes each prescription.
- Should the public dose schedule be followed?
- No. It conflicts with current branded injection escalation information. Obtain instructions for the actual preparation from the prescribing clinician.
- Is the dispensing pharmacy named?
- The offer refers to compounding partners but does not identify the facility assigned to a particular patient.
Sources
- Physician-directed service and nurse support
- Current compounded GLP-1 program scope
- William Cooper and clinical operations leadership
- Weight-loss and virtual-care bundle options
- Cooper and Company website agreement
- Current Wegovy injection dose escalation
- FDA consumer information on compounding
See what PRIMO Health Partners prescribes today
PRIMO Health Partners sets its own prices, plans and the states it serves. Check them before you start.